Table 3 BA, height, weight, IGF-1, HbA1c and thyroid function in the fourth proband after GH treatment
From: Molecular genetic analysis and growth hormone response in patients with syndromic short stature
CA (year) | BA (year) | Height (cm) | Weight (kg) | GH (IU/kg/d) | IGF-1 ng/mL | HbA1c (3.6–6.0%) | INS (2.6–11.8 µU/mL) | FT3 (pmol/L) | FT4 (pmol/L) | TSH (mIU/L) | Levothyroxine (µg) |
|---|---|---|---|---|---|---|---|---|---|---|---|
12–9/12 | 13.5 | 139.3 (− 2.69SD) | 30.4 (− 2.30SD) | 0.15 | 259 (143–693) | 5.2 | 6.9 | 6.3 (3.5–7.7) | 15.3 (12.0–22.0) | 4.19 (0.27–4.20) | |
13–1/12 | 140.2 (− 2.73SD) | 33.4 (− 1.88SD) | 0.15 | 361 (183–850) | 5.2 | 10.0 | 6.4 (3.5–7.7) | 12.3 (12.0–22.0) | 6.39↑ (0.27–4.20) | ||
13–7/12 | 14.5 | 144.0 (− 2.38SD) | 34.3 (− 2.04SD) | 0.16 | 503 (183–850) | 5.2 | 6.6 | 8.0 (3.5–7.7) | 15.4 (12.0–22.0) | 7.07↑ (0.27–4.20) | 25 |
13–11/12 | 145.0 (− 2.36SD) | 38.5 (− 1.43SD) |